标题
Lipoproteinapherese
作者
关键词
-
出版物
HERZ
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-22
DOI
10.1007/s00059-022-05115-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients
- (2021) J. Víšek et al. Orphanet Journal of Rare Diseases
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)
- (2019) Elisa Waldmann et al. PATHOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017
- (2019) Alison Pottle et al. ATHEROSCLEROSIS
- Treatment-related and health-related quality of life in lipoprotein apheresis patients
- (2018) V. De Gucht et al. Journal of Clinical Lipidology
- Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
- (2018) Günter Klaus et al. PEDIATRIC NEPHROLOGY
- Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort
- (2018) Sophie Beliard et al. ATHEROSCLEROSIS
- Epidemiology of familial hypercholesterolaemia: Community and clinical
- (2018) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs
- (2017) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
- (2016) Anthony Wang et al. Journal of the American Heart Association
- Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden
- (2015) J. Dittrich-Riediger et al. ATHEROSCLEROSIS SUPPLEMENTS
- Effects of different lipoprotein apheresis methods on serum protein levels
- (2015) U. Julius et al. ATHEROSCLEROSIS SUPPLEMENTS
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease
- (2013) Josef Leebmann et al. CIRCULATION
- Why an Apheresis Center Should Offer More Than One Lipoprotein Apheresis Method
- (2012) Ulrich Julius et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
- (2009) Beate R Jaeger et al. Nature Reviews Cardiology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started